- Home
- REE vs PRPH Comparison
REE vs PRPH Comparison
Compare REE & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- PRPH
- Stock Information
- Founded
- REE 2011
- PRPH 1989
- Country
- REE Israel
- PRPH United States
- Employees
- REE N/A
- PRPH N/A
- Industry
- REE Auto Manufacturing
- PRPH Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- PRPH Health Care
- Exchange
- REE Nasdaq
- PRPH Nasdaq
- Market Cap
- REE 18.5M
- PRPH 17.7M
- IPO Year
- REE N/A
- PRPH 1997
- Fundamental
- Price
- REE $0.69
- PRPH $0.35
- Analyst Decision
- REE Strong Buy
- PRPH
- Analyst Count
- REE 2
- PRPH 0
- Target Price
- REE $11.75
- PRPH N/A
- AVG Volume (30 Days)
- REE 85.2K
- PRPH 15.6M
- Earning Date
- REE 09-25-2025
- PRPH 08-13-2025
- Dividend Yield
- REE N/A
- PRPH N/A
- EPS Growth
- REE N/A
- PRPH N/A
- EPS
- REE N/A
- PRPH N/A
- Revenue
- REE $183,000.00
- PRPH $5,588,000.00
- Revenue This Year
- REE $6,661.20
- PRPH $221.82
- Revenue Next Year
- REE $2,240.01
- PRPH N/A
- P/E Ratio
- REE N/A
- PRPH N/A
- Revenue Growth
- REE N/A
- PRPH N/A
- 52 Week Low
- REE $0.53
- PRPH $0.22
- 52 Week High
- REE $11.72
- PRPH $3.00
- Technical
- Relative Strength Index (RSI)
- REE 45.75
- PRPH 49.12
- Support Level
- REE $0.65
- PRPH $0.28
- Resistance Level
- REE $0.73
- PRPH $0.44
- Average True Range (ATR)
- REE 0.05
- PRPH 0.04
- MACD
- REE 0.01
- PRPH -0.00
- Stochastic Oscillator
- REE 55.42
- PRPH 43.31
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About PRPH ProPhase Labs Inc. (DE)
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.